Andrew Peniket

1.8k total citations
22 papers, 772 citations indexed

About

Andrew Peniket is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Andrew Peniket has authored 22 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 10 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Andrew Peniket's work include Acute Myeloid Leukemia Research (11 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Retinoids in leukemia and cellular processes (4 papers). Andrew Peniket is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Retinoids in leukemia and cellular processes (4 papers). Andrew Peniket collaborates with scholars based in United Kingdom, United States and France. Andrew Peniket's co-authors include Timothy J. Littlewood, James S. Wainscoat, Jacqueline Boultwood, David Grimwade, Ellen Solomon, Joseph L. Wiemels, Neil Osheroff, Carolyn A. Felix, John Willan and Charles Craddock and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Andrew Peniket

21 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Peniket United Kingdom 12 479 329 177 171 110 22 772
Ching-Yuan Kuo Taiwan 5 764 1.6× 494 1.5× 156 0.9× 226 1.3× 182 1.7× 10 948
Kiminori Terui Japan 19 504 1.1× 380 1.2× 109 0.6× 194 1.1× 143 1.3× 71 885
Anna Grazia Recchia Italy 16 302 0.6× 265 0.8× 166 0.9× 154 0.9× 151 1.4× 38 653
Bhavana Bhatnagar United States 17 438 0.9× 390 1.2× 299 1.7× 158 0.9× 124 1.1× 79 877
Jason H. Mendler United States 13 298 0.6× 322 1.0× 198 1.1× 140 0.8× 71 0.6× 53 787
Jian‐Pei Fang China 14 301 0.6× 269 0.8× 95 0.5× 118 0.7× 201 1.8× 87 733
Na Xu China 17 560 1.2× 194 0.6× 215 1.2× 194 1.1× 220 2.0× 98 841
Dragana Janić Serbia 15 181 0.4× 175 0.5× 88 0.5× 179 1.0× 95 0.9× 70 722
A Ferster Belgium 12 237 0.5× 246 0.7× 99 0.6× 228 1.3× 107 1.0× 28 631
K.M. Kazemier Netherlands 13 204 0.4× 303 0.9× 261 1.5× 439 2.6× 46 0.4× 17 840

Countries citing papers authored by Andrew Peniket

Since Specialization
Citations

This map shows the geographic impact of Andrew Peniket's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Peniket with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Peniket more than expected).

Fields of papers citing papers by Andrew Peniket

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Peniket. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Peniket. The network helps show where Andrew Peniket may publish in the future.

Co-authorship network of co-authors of Andrew Peniket

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Peniket. A scholar is included among the top collaborators of Andrew Peniket based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Peniket. Andrew Peniket is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pillai, Lakshmi, Sue Pavord, Toby A. Eyre, et al.. (2023). Real world reduction in red cell transfusion with restrictive transfusion threshold in haematology inpatients. Transfusion Medicine. 33(3). 254–256. 2 indexed citations
2.
Loke, Justin, Aimee Jackson, Shamyla Siddique, et al.. (2023). Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS. Blood Advances. 7(14). 3666–3676. 21 indexed citations
3.
Willan, John, et al.. (2020). Care of haematology patients in a COVID‐19 epidemic. British Journal of Haematology. 189(2). 241–243. 58 indexed citations
4.
Sharpley, Faye, Grant Vallance, Fotios Panitsas, et al.. (2020). Myeloma clinical outcomes following the first wave of COVID‐19: results from the Thames Valley Cancer Alliance (UK). British Journal of Haematology. 192(6). e136–e139.
5.
Quek, Lynn, Paul Ferguson, Marlen Metzner, et al.. (2016). Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia. Blood Advances. 1(3). 193–204. 49 indexed citations
6.
Hamblin, Angela, Adam Burns, Ruth Clifford, et al.. (2014). Development and Evaluation of the Clinical Utility of a Next Generation Sequencing (NGS) Tool for Myeloid Disorders. Blood. 124(21). 2373–2373. 1 indexed citations
7.
Lau, I‐Jun, Dean Smith, Norbert Blesing, et al.. (2014). Bendamustine in combination with thalidomide and dexamethasone is a viable salvage option in myeloma relapsed and/or refractory to bortezomib and lenalidomide. Annals of Hematology. 94(4). 643–649. 14 indexed citations
8.
Baron, Frédéric, Myriam Labopin, Andrew Peniket, et al.. (2014). RIC Allo-SCT with Flu/Bu in Comparison to Flu/Mel for AML Results in Similar Overall Survival: A Report from the ALWP of the EBMT. Blood. 124(21). 545–545. 1 indexed citations
9.
Chen, Frederick, Andrew Peniket, Eleni Tholouli, et al.. (2014). CMV-Specific T-Cell Therapy Improves Immune Reconstitution Following Unrelated Donor HSCT: Results of a Randomized Controlled Trial. Biology of Blood and Marrow Transplantation. 20(2). S49–S49. 3 indexed citations
10.
MacEwen, Clare, et al.. (2013). Quiz Page September 2013. American Journal of Kidney Diseases. 62(3). A26–A29. 3 indexed citations
11.
Eyre, Toby A., Andrew J. King, Andrew Peniket, et al.. (2013). Partial engraftment following plerixafor rescue after failed sibling donor peripheral blood stem cell harvest. Transfusion. 54(5). 1231–1234. 5 indexed citations
12.
Jovanović, Jelena, Dominic Culligan, Andrew Peniket, et al.. (2011). Development of Real-Time Quantitative Polymerase Chain Reaction Assays to Track Treatment Response in Retinoid Resistant Acute Promyelocytic Leukemia. SHILAP Revista de lepidopterología. 1. 35–35. 18 indexed citations
13.
14.
15.
Mistry, Anita R., Carolyn A. Felix, Ryan J. Whitmarsh, et al.. (2005). DNA Topoisomerase II in Therapy-Related Acute Promyelocytic Leukemia. New England Journal of Medicine. 352(15). 1529–1538. 197 indexed citations
16.
Peniket, Andrew, James S. Wainscoat, Lucy Side, et al.. (2005). Del (9q) AML: clinical and cytological characteristics and prognostic implications. British Journal of Haematology. 129(2). 210–220. 29 indexed citations
17.
Sweetser, David A., Andrew Peniket, Yuntian Zhang, et al.. (2005). Delineation of the minimal commonly deleted segment and identification of candidate tumor‐suppressor genes in del(9q) acute myeloid leukemia. Genes Chromosomes and Cancer. 44(3). 279–291. 45 indexed citations
18.
Boultwood, Jacqueline, Andrew Peniket, Fiona Watkins, et al.. (2000). Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase. Blood. 96(1). 358–361. 52 indexed citations
19.
Boultwood, Jacqueline, Carrie Fidler, Patricia Shepherd, et al.. (1999). Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia. American Journal of Hematology. 61(1). 5–9. 44 indexed citations
20.
Mellanby, Jane, et al.. (1999). The effect of experimental epilepsy induced by injection of tetanus toxin into the amygdala of the rat on eating behaviour and response to novelty. Behavioural Brain Research. 100(1-2). 113–122. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ching-Yuan Kuo Breakdown of academic impact, for papers by Kiminori Terui Breakdown of academic impact, for papers by Anna Grazia Recchia Breakdown of academic impact, for papers by Bhavana Bhatnagar Breakdown of academic impact, for papers by Jason H. Mendler Breakdown of academic impact, for papers by Jian‐Pei Fang Breakdown of academic impact, for papers by Na Xu Breakdown of academic impact, for papers by Dragana Janić Breakdown of academic impact, for papers by A Ferster Breakdown of academic impact, for papers by K.M. Kazemier
Rankless by CCL
2026